Home/Vanqua Bio/Omer Siddiqui

OS

Omer Siddiqui

Chief Development Officer

Therapeutic Areas

Parkinson's Disease Alzheimer's Disease Dementia with Lewy Bodies Neurodegenerative Diseases

Vanqua Bio Pipeline

Drug	Indication	Phase
GCase Activator	GBA-Parkinson's Disease	Preclinical
Innate Immune System Modulator	Alzheimer's Disease / Related Disorders	Preclinical

Leadership Team at Vanqua Bio

Jim Sullivan, Ph.D.

Chief Executive Officer

Kevin Hunt, Ph.D.

Chief Scientific Officer

Maurizio Facheris, M.D.

Chief Medical Officer

Chief Business Officer

View full Vanqua Bio profile